SMRUTHI ORGANICS
|
SMRUTHI ORGANICS Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.99 | 3.11 | 3.14 | 3.61 | 9.07 |
| CEPS(Rs) | 8.54 | 7.92 | 8.08 | 7.60 | 12.79 |
| DPS(Rs) | 1.50 | 1.50 | 1.50 | 2.00 | 3.00 |
| Book NAV/Share(Rs) | 64.22 | 62.58 | 60.82 | 59.55 | 58.68 |
| Tax Rate(%) | 26.55 | 27.29 | 27.76 | 8.07 | 24.62 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.69 | 9.58 | 9.04 | 6.90 | 13.80 |
| EBIT Margin(%) | 6.18 | 5.33 | 4.82 | 3.75 | 11.05 |
| Pre Tax Margin(%) | 4.54 | 3.86 | 3.76 | 3.17 | 10.31 |
| PAT Margin (%) | 3.34 | 2.81 | 2.71 | 2.91 | 7.78 |
| Cash Profit Margin (%) | 9.52 | 7.14 | 6.99 | 6.14 | 10.96 |
| Performance Ratios | |||||
| ROA(%) | 3.14 | 3.07 | 3.18 | 4.24 | 11.57 |
| ROE(%) | 4.72 | 5.04 | 5.21 | 6.11 | 16.27 |
| ROCE(%) | 7.46 | 7.98 | 8.22 | 7.39 | 21.00 |
| Asset Turnover(x) | 0.94 | 1.09 | 1.17 | 1.46 | 1.49 |
| Sales/Fixed Asset(x) | 0.71 | 0.94 | 1.05 | 1.20 | 1.21 |
| Working Capital/Sales(x) | 3.93 | 3.94 | 3.97 | 4.75 | 3.62 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.41 | 1.07 | 0.95 | 0.83 | 0.83 |
| Receivable days | 91.99 | 105.63 | 107.56 | 84.30 | 68.12 |
| Inventory Days | 100.66 | 83.47 | 74.16 | 56.56 | 52.02 |
| Payable days | 119.78 | 118.73 | 134.43 | 71.26 | 57.14 |
| Valuation Parameters | |||||
| PER(x) | 32.24 | 35.42 | 46.58 | 35.61 | 24.69 |
| PCE(x) | 11.30 | 13.92 | 18.09 | 16.90 | 17.51 |
| Price/Book(x) | 1.50 | 1.76 | 2.40 | 2.16 | 3.82 |
| Yield(%) | 1.55 | 1.36 | 1.03 | 1.56 | 1.34 |
| EV/Net Sales(x) | 1.14 | 1.13 | 1.40 | 1.07 | 1.94 |
| EV/Core EBITDA(x) | 8.86 | 11.61 | 14.82 | 15.27 | 13.60 |
| EV/EBIT(x) | 18.36 | 21.05 | 27.96 | 28.41 | 17.53 |
| EV/CE(x) | 1.42 | 1.61 | 2.19 | 2.05 | 3.70 |
| M Cap / Sales | 1.08 | 1.00 | 1.31 | 1.04 | 1.92 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -19.08 | -1.28 | -9.50 | 5.75 | 5.43 |
| Core EBITDA Growth(%) | 7.25 | 1.99 | 21.67 | -47.99 | -34.65 |
| EBIT Growth(%) | -6.22 | 6.14 | 19.97 | -63.97 | -41.33 |
| PAT Growth(%) | -3.85 | -0.76 | -13.09 | -60.21 | -39.31 |
| EPS Growth(%) | -3.85 | -0.76 | -13.09 | -60.21 | -39.31 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.11 | 0.23 | 0.17 | 0.08 | 0.04 |
| Current Ratio(x) | 1.93 | 2.00 | 1.78 | 1.81 | 3.37 |
| Quick Ratio(x) | 0.92 | 1.12 | 1.08 | 1.16 | 2.09 |
| Interest Cover(x) | 3.77 | 3.62 | 4.53 | 6.46 | 15.00 |
| Total Debt/Mcap(x) | 0.08 | 0.13 | 0.07 | 0.04 | 0.01 |
Compare Financial Ratios of peers of SMRUTHI ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMRUTHI ORGANICS | ₹144.7 Cr | 9.1% | 6.9% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
SMRUTHI ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMRUTHI ORGANICS | 9.1% |
6.9% |
-11.8% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses
